InsidersTradesSigma
Explore the full record of transactions filed by Riebman Jerome, Directeur Médical. Director active across 1 company, notably Aziyo Biologics, INC.. In total, 1 disclosures have been recorded. History available since 8 March 2022. The latest transaction was disclosed on 8 March 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Jerome Riebman serves as Chief Medical Officer at AZIYO BIOLOGICS, INC. He is responsible for leading the company's medical affairs, ensuring that products and services meet health and safety standards. His role includes overseeing medical teams and managing risks associated with products. With his expertise, he contributes to AZIYO's mission of providing quality medical solutions.